Scientech Research’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
Other funds holding LABD
Scientech Research's LABD Position: Q3 2026 in Review
Scientech Research opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2026: 50,593 shares worth $356K. The stake represents 1.53% of the portfolio and ranks #27 among its holdings. This is a return to the name: Scientech Research previously reported a position in LABD as recently as Q3 2025.
Scientech Research first reported a position in LABD in Q1 2024 and has held it in 4 quarters since. The position peaked at $449K in Q1 2024. 20 funds tracked by Wall St. Rank hold LABD as of Q3 2026.
- Scientech Research held 50,593 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $356K as of Q3 2026.
- Direxion Daily S&P Biotech Bear 3X ETF was a new Scientech Research position in Q3 2026.
- Direxion Daily S&P Biotech Bear 3X ETF made up 1.53% of Scientech Research's portfolio in Q3 2026, its #27 holding.
- Scientech Research first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2024 and has held it in 4 quarters since.
- Scientech Research's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $449K in Q1 2024.
- 20 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2026.
Based on Scientech Research's 13F filing for Q3 2026, filed 16 Nov 2026.